FASD 儿童补充胆碱五年随访:非言语 IQ 与工作记忆仍高于安慰剂组
Choline supplementation in young children with fetal alcohol spectrum disorder can have durable developmental benefits
针对 2 至 5 岁胎儿酒精谱系障碍(FASD)儿童开展的三项随机对照试验,在五年后复评显示,曾接受 9 个月胆碱治疗的儿童非言语 IQ 平均高 7%、工作记忆评分高 9%,效应量为中到大。复评时共 58 名儿童,平均年龄 9 岁,较高剂量与更大认知获益相关。其他整体认知、记忆及家长评价的行为问题未见组间差异,研究者认为胆碱有潜力作为早期干预改变神经发育轨迹,剂量与时机仍需进一步研究。
三项 RCT 的五年随访显示,胆碱组非言语 IQ 与工作记忆仍高于安慰剂组,为 FASD 早期干预补上长期数据。
Children affected by prenatal alcohol exposure (PAE) experience long-lasting cognitive gains after treatment with supplemental choline, an essential nutrient, a new study suggests. The findings point to a potentially scalable intervention for neurodevelopmental differences that currently have few treatment options. Fetal alcohol spectrum disorder (FASD) is an umbrella term for several diagnoses that affect 1%–5% of the global population and can involve physical, cognitive and behavioral deficits and challenges.
Choline supplementation has been shown to benefit brain development in animal models of PAE. Prenatal choline supplementation during human pregnancies involving alcohol exposure has also shown benefits. While randomized controlled trials (RCTs) of FASD treatments have been scarce, researchers at the University of Minnesota previously conducted three such studies involving choline supplementation in young children. For the new study in Alcohol: Clinical & Experimental Research, investigators reassessed those children five years later.
The three RCTs collectively involved 104 children ages 2 to 5 at enrollment—each diagnosed with a form of FASD—and compared nine months of choline treatment with placebo in the 84 children who completed a trial. The children demonstrated improvements in sequential memory and delayed recall, with higher doses linked to greater benefits. For the follow-up, 58 of the children—average age 9—were reassessed.
Children treated with choline again performed better on tests of certain cognitive functions than those who received placebo. Nonverbal IQ was on average 7% higher, and working memory scores were 9% higher, in children treated with choline (medium to large effect sizes). One aspect of executive function (inhibition) showed nonsignificant benefits with a medium effect size. Higher doses of choline were linked to greater cognitive gains. The follow-up assessment did not reveal differences on other measures of global cognitive function, memory or behavioral issues rated by parents.
The new study identified cognitive gains that had not been apparent immediately after the RCTs. The findings suggest choline's potential as an early treatment to alter a child's neurodevelopmental trajectory and improve cognitive function over the long term. Choline is the only biological, evidence-based FASD treatment systematically tested with RCTs. Ongoing research is needed to refine dosing and timing.
More information
Jeffrey R. Wozniak et al., Long‐Term Neurodevelopmental Outcome Following Three Randomized Controlled Trials of Choline in Fetal Alcohol Spectrum Disorder ( FASD ), Alcohol, Clinical and Experimental Research (2026). DOI: 10.1111/acer.70394
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Choline supplementation in young children with fetal alcohol spectrum disorder can have durable developmental benefits (2026, October 12) retrieved 12 October 2026 from https://medicalxpress.com/news/2026-10-choline-supplementation-young-children-fetal.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com